1. A. Mazza, A. F. Cicero, E. Ramazzina, S. Lenti, L. Schiavon, E. Casiglia, G. Gussoni (2016).
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low
cardiovascular risk: a multicenter, randomized clinical trial. Journal of biological regulators andhomeostatic agents, 30(3), 921-927.
D. Serapinas, E. Boreikaitė, A. Bartkevičiūtė, R. Bandzevičienė, M. Šilkūnas, D. Bartkevičienė
(2017). The importance of folate, vitamins B6 and B12 for the lowering of homocysteine
concentrations for patients with recurrent pregnancy loss and MTHFR mutations. Reproductive toxicology, 72, 159-163.
A. Mech, A. Farah (2016). Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 77(5), 668-671.
L. Flicker, S. Vasikaran, Jenny Thomas, John Acres, P. Norman, K. Jamrozik, G. Hankey, O.
Almeida (2006). Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia. Stroke, 37(2), 547-549.
B.-J. Lee, M.-C. Huang, L.-J. Chung, C.-H. Cheng, K. Lin, K. Su, Y.-C. Huang (2004). Folic acid
and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. European Journal of Clinical Nutrition, 58, 481-487.